Centessa Pharmaceuticals plc CEO Saurabh Saha's 2022 pay falls 40% to $9.6M
Centessa Pharmaceuticals plc reports 2022 executive compensation
By ExecPay News
Published: May 9, 2024
Centessa Pharmaceuticals plc reported fiscal year 2022 executive compensation information on May 9, 2024.
In 2022, five executives at Centessa Pharmaceuticals plc received on average a compensation package of $4.2M, a 59% decrease compared to previous year.
Average pay of disclosed executives at Centessa Pharmaceuticals plc
Saurabh Saha, Chief Executive Officer, received $9.6M in total, which decreased by 40% compared to 2021. 50% of Saha's compensation, or $4.8M, was in option awards. Saha also received $324K in bonus, $621K in salary, $3.9M in stock awards, as well as $12K in other compensation.
Gregory Weinhoff, Chief Financial Officer, received a compensation package of $3.3M, which decreased by 18% compared to previous year. 44% of the compensation package, or $1.5M, was in option awards.
David Chao, Chief Administrative Officer, earned $3.3M in 2022, a 16% decrease compared to previous year.
Antoine Yver, Chairman, received $2.5M in 2022, which decreases by 85% compared to 2021.
David Grainger, Former Chief Innovation Officer, earned $2.4M in 2022.
Related executives
David Grainger
Centessa Pharmaceuticals plc
Former Chief Innovation Officer
Antoine Yver
Centessa Pharmaceuticals plc
Chairman
Saurabh Saha
Centessa Pharmaceuticals plc
Chief Executive Officer
Gregory Weinhoff
Centessa Pharmaceuticals plc
Chief Financial Officer
David Chao
Centessa Pharmaceuticals plc
Chief Administrative Officer
You may also like
Source: SEC filing on May 9, 2024.